Your browser doesn't support javascript.
loading
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer.
Hong, David S; Concin, Nicole; Vergote, Ignace; de Bono, Johann S; Slomovitz, Brian M; Drew, Yvette; Arkenau, Hendrik-Tobias; Machiels, Jean-Pascal; Spicer, James F; Jones, Robert; Forster, Martin D; Cornez, Nathalie; Gennigens, Christine; Johnson, Melissa L; Thistlethwaite, Fiona C; Rangwala, Reshma A; Ghatta, Srinivas; Windfeld, Kristian; Harris, Jeffrey R; Lassen, Ulrik Niels; Coleman, Robert L.
Afiliação
  • Hong DS; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. dshong@mdanderson.org.
  • Concin N; Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Vergote I; Oncology, University Hospitals Leuven, Leuven, Belgium.
  • de Bono JS; Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Slomovitz BM; Gynecologic Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
  • Drew Y; Medical Oncology, Northern Centre for Cancer Care, The Newcastle-upon-Tyne Hospitals NHS Foundation Trust and Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
  • Arkenau HT; Oncology, Sarah Cannon Research Institute, London, United Kingdom.
  • Machiels JP; Service d'Oncologie Médicale, Institut Roi Albert II, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, UCLouvain, Brussels, Belgium.
  • Spicer JF; Comprehensive Cancer Centre, King's College London, Guy's Hospital, London, United Kingdom.
  • Jones R; Biosciences, Cardiff University and Velindre NHS Trust, Cardiff, United Kingdom.
  • Forster MD; Department of Oncology, University College London Cancer Institute, University College London Hospitals, London, United Kingdom.
  • Cornez N; Oncology, Centre Hospitalier Universitaire Ambroise Paré, Mons, Belgium.
  • Gennigens C; Department of Medical Oncology, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
  • Johnson ML; Medical Oncology, Sarah Cannon Research Institute, Nashville, Tennessee.
  • Thistlethwaite FC; Medical Oncology, The Christie NHS Foundation Trust, The University of Manchester, Manchester, United Kingdom.
  • Rangwala RA; Medical, Genmab US, Inc., Princeton, New Jersey.
  • Ghatta S; Clinical Science, Genmab US, Inc., Princeton, New Jersey.
  • Windfeld K; Biostatistics, Genmab, Copenhagen, Denmark.
  • Harris JR; Translational Research, Genmab US, Inc., Princeton, New Jersey.
  • Lassen UN; Clinical Oncology, Rigshospitalet, Copenhagen, Denmark.
  • Coleman RL; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 26(6): 1220-1228, 2020 03 15.
Article em En | MEDLINE | ID: mdl-31796521

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Carcinoma de Células Escamosas / Neoplasias do Colo do Útero / Resistencia a Medicamentos Antineoplásicos / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Carcinoma de Células Escamosas / Neoplasias do Colo do Útero / Resistencia a Medicamentos Antineoplásicos / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article